Optimus Pharma Gets DCGI Nod for Conducting Phase-III Clinical Trials for Molnupiravir on Mild-to-Moderate Covid Patients
Optimus Pharma on Wednesday received DCGI nod for conducting phase-III clinical trials for orally-administered Molnupiravir capsules on patients with mild-to-moderate […]